Φορτώνει......
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
AIMS/HYPOTHESIS: Previous epidemiological studies have reported a potential link between insulin analogues and breast cancer; however, a prospective randomised controlled trial showed neutral effects of insulin glargine on cancer risk. Insulin glargine is metabolised in vivo to an M1 metabolite. A q...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Diabetologia |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970885/ https://ncbi.nlm.nih.gov/pubmed/27241182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-016-4000-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|